Algorhythm sees Q1 equity >$2.5M, expects Nasdaq compliance after warrant conversion

Algorhythm Holdings, Inc.

Stockholders' deficit was ~$10.5M at Dec 31, 2024 vs ~$2.7M equity at Sep 30, 2024.
Deficit driven by $16.6M warrant liability from Dec 2024 public offering.
In Q1 2025, Series B warrants fully exercised, Series A contingencies satisfied; liability reclassified to equity.
Expects >$2.5M equity for Mar 31, 2025, regaining compliance with Nasdaq Listing Rule 5550(b)(1).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.